完全胰腺切除术患者和健康个体对体外催产素的糖代谢反应。

IF 2.8 4区 医学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Peptides Pub Date : 2024-05-22 DOI:10.1016/j.peptides.2024.171242
Vivian Kliim-Hansen , Ida M. Gether , Caroline T.-B. Juel , Anne-Marie Ellegaard , Miriam G. Pedersen , Bolette Hartmann , Nicolai J. Wewer Albrechtsen , Jens J. Holst , Asger B. Lund , Lærke S. Gasbjerg , Filip K. Knop
{"title":"完全胰腺切除术患者和健康个体对体外催产素的糖代谢反应。","authors":"Vivian Kliim-Hansen ,&nbsp;Ida M. Gether ,&nbsp;Caroline T.-B. Juel ,&nbsp;Anne-Marie Ellegaard ,&nbsp;Miriam G. Pedersen ,&nbsp;Bolette Hartmann ,&nbsp;Nicolai J. Wewer Albrechtsen ,&nbsp;Jens J. Holst ,&nbsp;Asger B. Lund ,&nbsp;Lærke S. Gasbjerg ,&nbsp;Filip K. Knop","doi":"10.1016/j.peptides.2024.171242","DOIUrl":null,"url":null,"abstract":"<div><p>Oxytocin has been proposed to possess glucose-stabilizing effects through the release of insulin and glucagon from the pancreas. Also, exogenous oxytocin has been shown to stimulate extrapancreatic glucagon secretion in depancreatized dogs. Here, we investigated the effect of exogenous oxytocin on circulating levels of pancreatic and gut-derived glucose-stabilizing hormones (insulin [measured as C-peptide], glucagon, glucagon-like peptide 1 [GLP-1], and glucose-dependent insulinotropic polypeptide). We studied nine pancreatectomized (PX) patients and nine healthy controls (CTRLs) (matched on age and body mass index) before, during, and after an intravenous infusion of 10 IU of oxytocin administered over 12 min. Oxytocin did not increase plasma glucagon levels, nor induce any changes in plasma glucose, C-peptide, or GIP in any of the groups. Oxytocin decreased plasma glucagon levels by 19 ± 10 % in CTRLs (from 2.0 ± 0.5 [mean ± SEM] to 1.3 ± 0.2 pmol/l, <em>P</em> = 0.0025) and increased GLP-1 by 42 ± 22 % in PX patients (from 9.0 ± 1.0–12.7 ± 1.0 pmol/l, <em>P</em> = 0.0003). Fasting plasma glucose levels were higher in PX patients compared with CTRLs (13.1 ± 1.1 vs. 5.1 ± 0.1 mmol/l, <em>P</em> &lt; 0.0001). In conclusion, the present findings do not support pancreas-mediated glucose-stabilizing effects of acute oxytocin administration in humans and warrant further investigation of oxytocin’s gluco-metabolic effects.</p></div>","PeriodicalId":19765,"journal":{"name":"Peptides","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2024-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Gluco-metabolic response to exogenous oxytocin in totally pancreatectomized patients and healthy individuals\",\"authors\":\"Vivian Kliim-Hansen ,&nbsp;Ida M. Gether ,&nbsp;Caroline T.-B. Juel ,&nbsp;Anne-Marie Ellegaard ,&nbsp;Miriam G. Pedersen ,&nbsp;Bolette Hartmann ,&nbsp;Nicolai J. Wewer Albrechtsen ,&nbsp;Jens J. Holst ,&nbsp;Asger B. Lund ,&nbsp;Lærke S. Gasbjerg ,&nbsp;Filip K. Knop\",\"doi\":\"10.1016/j.peptides.2024.171242\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Oxytocin has been proposed to possess glucose-stabilizing effects through the release of insulin and glucagon from the pancreas. Also, exogenous oxytocin has been shown to stimulate extrapancreatic glucagon secretion in depancreatized dogs. Here, we investigated the effect of exogenous oxytocin on circulating levels of pancreatic and gut-derived glucose-stabilizing hormones (insulin [measured as C-peptide], glucagon, glucagon-like peptide 1 [GLP-1], and glucose-dependent insulinotropic polypeptide). We studied nine pancreatectomized (PX) patients and nine healthy controls (CTRLs) (matched on age and body mass index) before, during, and after an intravenous infusion of 10 IU of oxytocin administered over 12 min. Oxytocin did not increase plasma glucagon levels, nor induce any changes in plasma glucose, C-peptide, or GIP in any of the groups. Oxytocin decreased plasma glucagon levels by 19 ± 10 % in CTRLs (from 2.0 ± 0.5 [mean ± SEM] to 1.3 ± 0.2 pmol/l, <em>P</em> = 0.0025) and increased GLP-1 by 42 ± 22 % in PX patients (from 9.0 ± 1.0–12.7 ± 1.0 pmol/l, <em>P</em> = 0.0003). Fasting plasma glucose levels were higher in PX patients compared with CTRLs (13.1 ± 1.1 vs. 5.1 ± 0.1 mmol/l, <em>P</em> &lt; 0.0001). In conclusion, the present findings do not support pancreas-mediated glucose-stabilizing effects of acute oxytocin administration in humans and warrant further investigation of oxytocin’s gluco-metabolic effects.</p></div>\",\"PeriodicalId\":19765,\"journal\":{\"name\":\"Peptides\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2024-05-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Peptides\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0196978124000950\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Peptides","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0196978124000950","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

催产素被认为可通过从胰腺释放胰岛素和胰高血糖素来起到稳定血糖的作用。此外,外源性催产素还能刺激去势犬胰腺外胰高血糖素的分泌。在此,我们研究了外源性催产素对循环中胰腺和肠道来源的葡萄糖稳定激素(胰岛素 [以 C 肽衡量]、胰高血糖素、胰高血糖素样肽 1 [GLP-1] 和葡萄糖依赖性促胰岛素多肽)水平的影响。我们研究了九名胰腺切除术(PX)患者和九名健康对照组(CTRLs)(年龄和体重指数相匹配)在 12 分钟内静脉注射 10 IU 催产素之前、期间和之后的情况。催产素不会增加血浆胰高血糖素水平,也不会引起血浆葡萄糖、C 肽或 GIP 的任何变化。催产素使 CTRL 患者的血浆胰高血糖素水平降低了 19 ± 10%(从 2.0 ± 0.5 [mean ± SEM] 降至 1.3 ± 0.2 pmol/l,P = 0.0025),使 PX 患者的 GLP-1 水平升高了 42 ± 22%(从 9.0 ± 1.0 升至 12.7 ± 1.0 pmol/l,P = 0.0003)。与 CTRLs 相比,PX 患者的空腹血浆葡萄糖水平更高(13.1 ± 1.1 vs. 5.1 ± 0.1mmol/l,P < 0.0001)。总之,目前的研究结果并不支持人体急性注射催产素后胰腺介导的葡萄糖稳定作用,因此有必要进一步研究催产素的葡萄糖代谢作用。试验注册 ClinicalTrials.gov NCT02944110。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Gluco-metabolic response to exogenous oxytocin in totally pancreatectomized patients and healthy individuals

Oxytocin has been proposed to possess glucose-stabilizing effects through the release of insulin and glucagon from the pancreas. Also, exogenous oxytocin has been shown to stimulate extrapancreatic glucagon secretion in depancreatized dogs. Here, we investigated the effect of exogenous oxytocin on circulating levels of pancreatic and gut-derived glucose-stabilizing hormones (insulin [measured as C-peptide], glucagon, glucagon-like peptide 1 [GLP-1], and glucose-dependent insulinotropic polypeptide). We studied nine pancreatectomized (PX) patients and nine healthy controls (CTRLs) (matched on age and body mass index) before, during, and after an intravenous infusion of 10 IU of oxytocin administered over 12 min. Oxytocin did not increase plasma glucagon levels, nor induce any changes in plasma glucose, C-peptide, or GIP in any of the groups. Oxytocin decreased plasma glucagon levels by 19 ± 10 % in CTRLs (from 2.0 ± 0.5 [mean ± SEM] to 1.3 ± 0.2 pmol/l, P = 0.0025) and increased GLP-1 by 42 ± 22 % in PX patients (from 9.0 ± 1.0–12.7 ± 1.0 pmol/l, P = 0.0003). Fasting plasma glucose levels were higher in PX patients compared with CTRLs (13.1 ± 1.1 vs. 5.1 ± 0.1 mmol/l, P < 0.0001). In conclusion, the present findings do not support pancreas-mediated glucose-stabilizing effects of acute oxytocin administration in humans and warrant further investigation of oxytocin’s gluco-metabolic effects.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Peptides
Peptides 医学-生化与分子生物学
CiteScore
6.40
自引率
6.70%
发文量
130
审稿时长
28 days
期刊介绍: Peptides is an international journal presenting original contributions on the biochemistry, physiology and pharmacology of biological active peptides, as well as their functions that relate to gastroenterology, endocrinology, and behavioral effects. Peptides emphasizes all aspects of high profile peptide research in mammals and non-mammalian vertebrates. Special consideration can be given to plants and invertebrates. Submission of articles with clinical relevance is particularly encouraged.
期刊最新文献
Lasso peptides realm: Insights and applications Maternal separation alters peripheral immune responses associated with IFN-γ and OT in mice Host defense peptides in crocodilians – A comprehensive review Cm-p5, a molluscan-derived antifungal peptide exerts its activity by a membrane surface covering in a non-penetrating mode Suppression of B-type natriuretic peptide gene expression in cardiomyocytes under anoxic conditions
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1